Nicholas Poe Associate Litigation Nicholas represents technology and life sciences companies in a broad range of securities litigation matters.
Media Coverage Fenwick’s Sheeva Ghassemi-Vanni Talks with Protocol about Legal and Practical Considerations for Performance Improvement Plans (PIPs) January 18, 2022
Experience Fenwick Represents Royalty Pharma in Funding Agreements with Cytokinetics Totaling up to $450M January 10, 2022
